Several HERV subfamilies, LTR21B, MER57F, and HERVL74-int (ERVL), were also identified as the top TE correlates to gene expression levels of type II IFN response, CD8 T effector and immune checkpoint activity inferred from tumor bulk tissue. The gene discussed is CD8A; the disease is neoplasm.